## **Core Concept**
TRALI (Transfusion-Related Acute Lung Injury) is a serious complication of blood transfusion characterized by the onset of non-cardiogenic pulmonary edema. It is primarily associated with the transfusion of antibodies against leukocyte antigens. The condition results from the activation of immune cells and the release of inflammatory mediators.

## **Why the Correct Answer is Right**
The correct answer, **Anti-leukocyte antibodies**, is right because TRALI is most commonly caused by the presence of anti-leukocyte antibodies (HLA or HNA) in the transfused blood product, usually directed against the recipient's leukocytes. These antibodies can activate the recipient's neutrophils, leading to their sequestration in the lungs, damage to the endothelial cells, and increased vascular permeability, which manifests as non-cardiogenic pulmonary edema.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while ABO incompatibility can cause hemolytic reactions, it is not a primary cause of TRALI.
- **Option B:** This option is incorrect as there is no well-established direct link between TRALI and the presence of **Anti-erythrocyte antibodies**; these are more commonly associated with hemolytic transfusion reactions.
- **Option C:** This option is incorrect because **Autoantibodies** are not typically implicated in the pathogenesis of TRALI; the condition is primarily associated with alloantibodies (antibodies against antigens from another individual of the same species).

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that TRALI is one of the leading causes of transfusion-related mortality. It typically presents within 6 hours of transfusion with symptoms such as respiratory distress, hypoxemia, and bilateral lung infiltrates on chest radiograph. The diagnosis is often one of exclusion, and management involves supportive care.

## **Correct Answer:** . Anti-leukocyte antibodies